N
Nicoletta Ronda
Researcher at University of Parma
Publications - 68
Citations - 2218
Nicoletta Ronda is an academic researcher from University of Parma. The author has contributed to research in topics: Cholesterol & Medicine. The author has an hindex of 21, co-authored 55 publications receiving 1815 citations.
Papers
More filters
Journal ArticleDOI
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Yehuda Shoenfeld,Roberto Gerli,Andrea Doria,Eiji Matsuura,Marco Matucci Cerinic,Nicoletta Ronda,Luis J. Jara,Mahmud Abu-Shakra,Pier Luigi Meroni,Yaniv Sherer,Yaniv Sherer +10 more
TL;DR: Several AIRDs exhibit increased overt cardiovascular disease (CVD) prevalence as well as findings of advanced subclinical atherosclerosis, which may precede the appearance of a clinical disease and thus be a target of early identification and preventive therapy.
Journal ArticleDOI
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus
Nicoletta Ronda,Elda Favari,Maria Orietta Borghi,Francesca Ingegnoli,Maria Gerosa,Cecilia Beatrice Chighizola,Francesca Zimetti,Maria Pia Adorni,Franco Bernini,Pier Luigi Meroni +9 more
TL;DR: In this paper, the capacity of high-density lipoproteins (HDL) to promote cell cholesterol efflux is investigated in rheumatoid arthritis (RA) and systemic lupus erythemathosus (SLE) patients.
Journal ArticleDOI
Probucol Inhibits ABCA1-Mediated Cellular Lipid Efflux
Elda Favari,Ilaria Zanotti,Francesca Zimetti,Nicoletta Ronda,Franco Bernini,George H. Rothblat +5 more
TL;DR: Probucol is an effective inhibitor of ABCA1-mediated cholesterol efflux without influencing scavenger receptor class B type I–mediated efflux, which may in part explain the reported in vivo high-density lipoprotein–lowering action of probucol.
Journal ArticleDOI
Newly Identified Antiatherosclerotic Activity of Methotrexate and Adalimumab: Complementary Effects on Lipoprotein Function and Macrophage Cholesterol Metabolism
Nicoletta Ronda,D. Greco,Maria Pia Adorni,Francesca Zimetti,Elda Favari,Gunnbjørg Hjeltnes,Knut Mikkelsen,Maria Orietta Borghi,Ennio Giulio Favalli,Rita Gatti,Ivana Hollan,Pier Luigi Meroni,Franco Bernini +12 more
TL;DR: The aim of this study was to investigate the influence of MTX and adalimumab treatment on serum cholesterol efflux capacity (CEC) and CLC in RA patients and to study the in vitro effects of the two drugs on macrophage cholesterol handling.
Journal ArticleDOI
A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus.
Viorel Simion,Haoyang Zhou,Haoyang Zhou,Stefan Haemmig,Jacob B. Pierce,Jacob B. Pierce,Shanelle Mendes,Yevgenia Tesmenitsky,Daniel Pérez-Cremades,James F. Lee,Alex F. Chen,Nicoletta Ronda,Bianca Papotti,Jarrod A. Marto,Jarrod A. Marto,Mark W. Feinberg +15 more
TL;DR: A mechanism by which a macrophage-specific lncRNA interacting with HuR regulates apoptosis is established, with implications for a broad range of vascular disease states.